Piperlongumine promotes death of retinoblastoma cancer cells
PDF | Full Text | How to cite
Metrics: PDF 989 views | Full Text 2262 views | ?
Nathalie Allaman-Pillet1 and Daniel F. Schorderet1,2,3
1 Institute for Research in Ophthalmology, Sion, Switzerland
2 University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland
3 Ecole Polytechnique Fédérale de Lausanne, Faculty of Life Sciences, Lausanne, Switzerland
|Nathalie Allaman-Pillet,||email:||[email protected]|
Keywords: cancer; retinoblastoma; piperlongumine; programmed cell death
Received: May 04, 2020 Accepted: April 01, 2021 Published: April 27, 2021
Retinoblastoma is the most common pediatric intraocular malignant tumor. While retinoblastoma initiation is triggered by the inactivation of both alleles of the retinoblastoma tumor suppressor gene (RB1) in the developing retina, tumor progression requires additional epigenetic changes, retinoblastoma genomes being quite stable. Although the management of RB has recently improved, new therapeutic agents are necessary to improve the treatment of advanced forms of retinoblastoma.
In this report, we analyzed the pro-death effect of piperlongumine (PL), a natural compound isolated from Piper longum L., on two human retinoblastoma cell lines, WERI-Rb and Y79. The effects of PL on cell proliferation, cell death and cell cycle were investigated. PL effectively inhibited cell growth, impacted the cell cycle by decreasing the level of cyclins and CDK1 and increasing CDKN1A and triggered a caspase-3 independant cell death process in which reactive oxygen species (ROS) production is a major player. Indeed, PL toxicity in retinoblastoma cell lines was inhibited by a ROS scavenger N-acetyl-l-cysteine (NAC) treatment. These findings suggest that PL reduces tumor growth and induces cell death by regulating the cell cycle.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.